pe
pep-05154 v1 CC-BY-SA-4.0

Glucagon-3 metabolic peptide

An experimental peptide that hits the same target as weight-loss drugs like Ozempic, being studied for blood sugar and metabolism; not an approved medicine.

statuscomputed targetGLP-1R length31 aa refs1
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.924
pTM0.830
avg pLDDT73.3
ranking score0.771
STRUCTURE · PEP-05154 × GLP-1R
ranking0.771
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence31 aa
15101520253031
HSQGMFTNDFSKYLEE EHAKEFVEWLKNGKS
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.9240871667861938 boltz-2
ranking score 0.7714747786521912 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.903global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
His-Ser-Gln-Gly-Met-Phe-Thr-Asn-Asp-Phe-Ser-Lys-Tyr-Leu-Glu-Glu-Glu-His-Ala-Lys-Glu-Phe-Val-Glu-Trp-Leu-Lys-Asn-Gly-Lys-Ser
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Glucagon-3 metabolic peptide (pep-05154, v1). PeptideModel. https://peptidemodel.com/card/pep-05154
@peptide{pep05154,
  sequence = {HSQGMFTNDFSKYLEEEHAKEFVEWLKNGKS},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 3 by signal overlap
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use